Becker F, Nusko G, Welke J, Hahn E G, Mansmann U
Department of Medical Biometry and Informatics, University of Heidelberg, 69120, Heidelberg, Germany.
Int J Colorectal Dis. 2007 Aug;22(8):929-39. doi: 10.1007/s00384-006-0252-0. Epub 2007 Feb 6.
For colorectal screening patients a mean gain of life time was previously calculated of about 30-50 days. Different recommendations for recognising at-risk groups and defining surveillance intervals after an initial finding of colorectal adenomas have been published. However, no benefit-risk analysis regarding to specific long-term effects of follow-up has been reported to date.
A Markov model based on time-dependent transition possibilities was developed to perform a benefit-risk analysis of the risk-related surveillance recommendations based on the Erlangen Registry of Colorectal Polyps (ERCRP) in comparison with the recommendation of the German Society of Gastrointestinal Diseases and Nutrition (DGVS). The outcome was calculated for a 50-year-old patient with 30 years of follow-up after initial polypectomy. The data used in this model were taken from different sources, namely the ERCRP, the German Study Group of Colorectal Cancer, the German Statistical Yearbook, and from meta-analyses of studies reporting data on complications and sensitivity of colonoscopy.
Patients under surveillance have a mean lifetime gain of 98 (ERCRP) and 110 (DGVS) days compared with those who do not come for surveillance. 84% and 94% of deaths from colorectal carcinoma (CRC) could be prevented if patients were followed up according to the recommendations of the ERCRP and the DGVS, respectively. Less colonoscopies are needed to prevent one death from CRC following the recommendations of the ERCRP (221) than those of the DGVS (283). The risk of death due to colonoscopy for patients during follow-up is about 0.05% lifetime risk. Sensitivity analysis showed the stability of the results under a wide range of reasonable variations of relevant parameters. In a pessimistic one-way sensitivity analysis regarding compliance, effectiveness was reduced to one third.
Surveillance using colonoscopy is an effective tool for preventing CRC after colorectal polypectomy, especially if a good compliance is assumed. The effectiveness is higher following the recommendations of the DGVS, but more colonoscopies are needed.
对于接受结直肠癌筛查的患者,此前计算出的平均寿命延长约为30 - 50天。关于识别高危人群以及在首次发现结直肠腺瘤后确定监测间隔的不同建议已发表。然而,迄今为止,尚未有关于随访特定长期影响的效益风险分析报告。
开发了一种基于时间依赖性转移可能性的马尔可夫模型,以对基于埃尔朗根结直肠息肉登记处(ERCRP)的风险相关监测建议与德国胃肠病与营养学会(DGVS)的建议进行效益风险分析。结果是针对一名50岁患者在首次息肉切除术后进行30年随访计算得出的。该模型中使用的数据来自不同来源,即ERCRP、德国结直肠癌研究组、德国统计年鉴以及关于结肠镜检查并发症和敏感性数据报告研究的荟萃分析。
与未接受监测的患者相比,接受监测的患者平均寿命延长98天(ERCRP)和110天(DGVS)。如果按照ERCRP和DGVS的建议对患者进行随访,分别可预防84%和94%的结直肠癌(CRC)死亡。按照ERCRP的建议(221次)预防一例CRC死亡所需的结肠镜检查次数比DGVS的建议(283次)少。随访期间患者因结肠镜检查导致的死亡风险约为0.05%的终身风险。敏感性分析表明,在相关参数的广泛合理变化范围内结果具有稳定性。在关于依从性的悲观单向敏感性分析中,有效性降至三分之一。
结肠镜检查监测是结直肠息肉切除术后预防CRC的有效工具,尤其是在假设依从性良好的情况下。遵循DGVS的建议有效性更高,但需要更多的结肠镜检查。